RDX antibody

Ref. 3D-70R-19843

Produktinformation

• Name: RDX antibody
• Marke: Biosynth
• Beschreibung: The RDX antibody is a monoclonal antibody that targets the epidermal growth factor (EGF) and has been shown to inhibit microvessel density. This antibody is commonly used in bioassays to study the effects of EGF on various cellular processes. It specifically binds to EGF and prevents its interaction with its receptor, thereby blocking downstream signaling pathways involved in cell proliferation, migration, and survival. The RDX antibody has also been found to have cytotoxic effects on certain cancer cells, making it a potential therapeutic option for cancer treatment. Additionally, this antibody has been used in combination with other drugs, such as imatinib, to enhance their efficacy in targeting specific cancer types. With its high specificity and potency, the RDX antibody is a valuable tool for researchers studying EGF-related pathways and exploring new treatment options for various diseases.